V142I トランスチレチン変異の心血管負担
Senthil Selvaraj1,2, Brian Claggett3, Svati H Shah1,2
1Division of Cardiology, Department of Medicine, Duke University Medical Center, Durham, North Carolina.
JAMA
|May 12, 2024
まとめ
トランスチレチン (TTR) V142Iの変種は,黒人の心不全 (HF) と死亡リスクを著しく増加させる. この変異はかなりの寿命の喪失と関連しており,標的治療の必要性を強調しています.
科学分野:
- 遺伝 と 心血管 疾患
- 人口の健康と疫学
背景:
- トランスチレチン (TTR) V142Iの変種は,米国黒人の3-4%で流行しており,心不全 (HF) と死亡リスクの増加に関連しています.
- 標的治療の開発には,キャリアリスクと集団負担を理解することが不可欠です.
研究 の 目的:
- TTR V142I変異媒体の自然史を生命の中期から後期まで定義する.
- 変異変因子を評価し,米国黒人人口の心血管疾患負担を推定する.
主な方法:
- 平均追跡期間は15. 5年,米国の4つの観察研究から自己報告された23,338人の黒人の参加者を分析した.
- HFの入院率と全原因死亡率の評価は,年齢による10年間の危険比率を用いて行われました.
- 平均生存率と人口負担の推定は,精算学的な方法と米国国勢調査データを用いた.
主要な成果:
- V142Iキャリア状態 (3. 2%) は,63歳までにHF入院の10年リスク増加と72歳までに全原因死亡率に関連していました.
- 年齢はリスクの主な変化因子であり,長寿の減少は1. 9から2. 8年であった.
- 推定435,851人の米国黒人キャリア (50~95歳) は,この変種のために累積的に957,000年以上の寿命を失う可能性がある.
結論:
- TTR V142Iのキャリアは,HF入院と死亡の実質的な,年齢に依存するリスクを経験します.
- 心血管疾患におけるV142I変種,祖先,人種,社会的健康決定因子の相互作用を理解するためにさらなる研究が必要である.
関連する概念動画
01:27Principles of Pharmacogenetics: Types of Genetic Variants
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
01:30Acute Coronary Syndrome III: Diagnostic Studies
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
01:25Cardiomyopathy I: Introduction and Classification
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
01:30Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
01:29Cardiomyopathy IV: Restrictive Cardiomyopathy
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...